CatalystPit

OCGNOcugen, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $1.03 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$349.28M
RECENT INSIDER TRADES
  • 2026-09-11 · Musunuri Shankar (Chief Executive Officer) · SELL
  • 2026-06-17 · Johnson-Greene Treerita Essalima (Chief Financial Officer) · BUY
  • 2026-04-02 · Zhang Junge (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders161
Shares held180,880,550
Value$269.83M
Percent of shares outstanding53.34%
As of quarter end2026-06-30
RECENT NEWS
  • Did Ocugen, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
  • Ocugen appoints Jolanda Crombach general manager of European affiliate
  • Ocugen to present gene therapy platform at scientific conferences
  • Ocugen to present at upcoming investor and industry conferences
  • Ocugen gets provisional approval in Bahamas for OCU400 retinitis pigmentosa therapy
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS